Emerging Therapeutics and Evolving Inhalation Applications
Patient-focused data for smarter product decisions
Inhalation and nasal delivery aren’t just for respiratory disease anymore.
We support development programs across an expanding range of inhaled and nasal products, including:
Intranasal vaccines and biologics
Systemic and CNS delivery via nose-to-brain approaches
Nicotine and cannabis products for regulated adult-use markets
Hormonal therapies, analgesics, and anti-nausea agents
Psychedelic and novel therapeutics
Our experience spans both controlled substance products and FDA-regulated drug development programs. We help developers navigate safety, quality, and performance expectations—even in emerging therapeutic areas where regulatory pathways are still evolving.
Ready to Accelerate Your Goals?
Schedule a 30-minute consultation and see how Proveris Labs can accelerate your goals. Contact us today.